Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3138267 | 0.95 | THRB (0.40) | THRBPOLBAPEX1HTTTDP1 | |
| SCHEMBL8982153 | 0.94 | THRB (0.39) | THRBPOLBAPEX1HTTTDP1 | |
| SCHEMBL7519970 | 0.92 | CYP2C19 (0.50) | THRBPOLBAPEX1HTTTDP1 | |
| SCHEMBL13261677 | 0.90 | THRB (0.40) | THRBPOLBAPEX1HTTTDP1 | |
| SCHEMBL13484338 | 0.89 | LMNA (0.36) | THRBPOLBAPEX1HTTTDP1 | |
| SCHEMBL13696520 | 0.88 | CYP2C19 (0.43) | THRBPOLBAPEX1HTTTDP1 | |
| SCHEMBL4457186 | 0.88 | CYP1A2 (0.40) | THRBPOLBAPEX1HTTTDP1 | |
| SCHEMBL12960322 | 0.87 | HRH3 (0.42) | THRBPOLBAPEX1HTTTDP1 | |
| SCHEMBL14139774 | 0.85 | TDP1 (0.36) | THRBPOLBAPEX1HTTTDP1 | |
| SCHEMBL13261678 | 0.85 | TDP1 (0.36) | THRBPOLBAPEX1HTTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0716102-B1 | TRANSPARENT PLASTIC MATERIAL, OPTICAL ARTICLE MADE THEREFROM, AND PRODUCTION PROCESS | SEIKO EPSON CORP (JP) | 2002-02-06 | — | — | EP | claimed |
| US-7569619-B2 | Radiation-curable resin composition and cured product thereof | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-08-04 | — | — | US | disclosed |
| WO-2008101806-A2 | HIGH REFRACTIVE INDEX MONOMERS, COMPOSITIONS AND USES THEREOF | BASF SE (CH) | 2008-08-28 | — | — | WO | disclosed |
| US-20080200582-A1 | High refractive index monomers, compositions and uses thereof | CIBA CORP. | 2008-08-21 | — | — | US | disclosed |
| US-20080200582-A1 | High refractive index monomers, compositions and uses thereof | CIBA CORP. | 2008-08-21 | — | — | US | disclosed |
| US-20080200582-A1 | High refractive index monomers, compositions and uses thereof | CIBA CORP. | 2008-08-21 | — | — | US | disclosed |
| US-20080102262-A1 | Radiation Curable Composition and Curing Product Thereof, and Laminate Including the Same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2008-05-01 | — | — | US | disclosed |
| US-20070231527-A1 | Optical Recording Medium and Method for Producing Same | MITSUBISHI KAGAKU MEDIA CO., LTD. (JP) | 2007-10-04 | — | — | US | disclosed |
| EP-1811517-A1 | OPTICAL RECORDING MEDIUM AND METHOD FOR PRODUCING SAME | Mitsubishi Kagaku Media Co., Ltd. (JP) | 2007-07-25 | — | — | EP | disclosed |
| US-7006344-B2 | Capacitor comprising bis(4-mercaptophenyl) sulfide derivative | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2006-02-28 | — | — | US | disclosed |
| US-20050267230-A1 | Radiation-curable resin composition and cured product thereof | MITSUBISHI CHEMICAL CORPORATION (JP) | 2005-12-01 | — | — | US | disclosed |
| EP-1561765-A1 | RADIATION CURING RESIN COMPOSITION AND CURED PRODUCT THEREOF | Mitsubishi Chemical Corporation (JP) | 2005-08-10 | — | — | EP | disclosed |
| US-20030189808-A1 | Bis(4-mercaptophenyl)sulfide derivatives, process for the preparation thereof and electronic components | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2003-10-09 | — | — | US | disclosed |
| EP-0940694-B1 | Photochromic curable composition | TOKUYAMA CORP (JP) | 2002-08-14 | — | — | EP | disclosed |
| EP-0716102-B1 | TRANSPARENT PLASTIC MATERIAL, OPTICAL ARTICLE MADE THEREFROM, AND PRODUCTION PROCESS | SEIKO EPSON CORP (JP) | 2002-02-06 | — | — | EP | disclosed |
| US-6194511-B1 | COMPRISING POLYMERIZABLE MONOMER CONTAINING SULFUR-CONTAINING (METH)ACRYLATE POLYMERIZABLE MONOMER AND PHOTOCHROMIC COMPOUND | TOKUYAMA CORPORATION (JP) | 2001-02-27 | — | — | US | disclosed |
| EP-0940694-A1 | Photochromic curable composition | TOKUYAMA CORPORATION (JP) | 1999-09-08 | — | — | EP | disclosed |
| US-5792822-A | COMPRISING A METAL COMPLEXES AS ULTRAVIOLET LIGHT ADSORBER AND BLOCKING AGENT; RADIATION RESISTANCE, LIGHTWEIGHT, STABILITY; EYEGLASS LENS, CONTACT LENS, DISPLAY FILTER | SEIKO EPSON CORPORATION (JP) | 1998-08-11 | — | — | US | disclosed |
| EP-0716102-A1 | TRANSPARENT PLASTIC MATERIAL, OPTICAL ARTICLE MADE THEREFROM, AND PRODUCTION PROCESS | SEIKO EPSON CORPORATION (JP) | 1996-06-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030189808-A1 | Bis(4-mercaptophenyl)sulfide derivatives, process for the preparation thereof and electronic components | SULT1E1, CBS, EPB41 | THRB 4520/4885POLB 3754/4885APEX1 479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.